Allianz Asset Management GmbH Trims Stake in ICU Medical, Inc. $ICUI

Allianz Asset Management GmbH cut its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 64.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 11,610 shares of the medical instruments supplier’s stock after selling 20,896 shares during the quarter. Allianz Asset Management GmbH’s holdings in ICU Medical were worth $1,393,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. AQR Capital Management LLC lifted its stake in shares of ICU Medical by 2.5% in the 1st quarter. AQR Capital Management LLC now owns 9,360 shares of the medical instruments supplier’s stock valued at $1,297,000 after purchasing an additional 229 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in ICU Medical by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,764 shares of the medical instruments supplier’s stock valued at $1,772,000 after buying an additional 560 shares during the period. United Services Automobile Association purchased a new position in ICU Medical in the first quarter valued at $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of ICU Medical by 32.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 68,211 shares of the medical instruments supplier’s stock worth $9,472,000 after acquiring an additional 16,680 shares during the period. Finally, Intech Investment Management LLC raised its position in shares of ICU Medical by 38.6% in the first quarter. Intech Investment Management LLC now owns 11,938 shares of the medical instruments supplier’s stock worth $1,658,000 after acquiring an additional 3,326 shares during the period. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Price Performance

ICU Medical stock opened at $144.90 on Friday. The company has a fifty day simple moving average of $148.95 and a 200-day simple moving average of $135.09. The firm has a market capitalization of $3.58 billion, a price-to-earnings ratio of -467.40 and a beta of 0.79. The company has a quick ratio of 1.19, a current ratio of 2.45 and a debt-to-equity ratio of 0.62. ICU Medical, Inc. has a 52-week low of $107.00 and a 52-week high of $165.17.

Analyst Ratings Changes

ICUI has been the topic of a number of analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of ICU Medical in a research report on Thursday, January 22nd. Wall Street Zen downgraded ICU Medical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Piper Sandler boosted their price objective on ICU Medical from $153.00 to $172.00 and gave the company an “overweight” rating in a research report on Friday, November 7th. Finally, KeyCorp upped their target price on ICU Medical from $173.00 to $175.00 and gave the stock an “overweight” rating in a research note on Friday, November 7th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, ICU Medical presently has a consensus rating of “Moderate Buy” and a consensus price target of $175.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.